Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Johannesburg Stock Exchange  >  Clicks Group Limited    CLS   ZAE000134854

CLICKS GROUP LIMITED

(CLS)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Clicks : EARNINGS UP 14% AS CLICKS GROUP POSTS RESILIENT PERFORMANCE IN COVID-19 CRISIS

10/22/2020 | 02:10am EST

Cape Town - Clicks Group delivered a strong and resilient performance in the Covid-19 environment, increasing diluted headline earnings per share by 13.7% to 754 cents for the year to August 2020. Earnings growth was driven mainly by tight cost management, solid retail health and beauty sales and the strong performance of UPD, the group's pharmaceutical wholesaler.

Shareholders will receive a dividend of 450 cents per share, based on a dividend payout ratio of 60%.

Group turnover increased by 9.6% to R34.4 billion and profit after tax grew by 11.8%. After returning R1.5 billion to shareholders in dividends and share buybacks, the group's cash balance totalled R2.2 billion at year end.

Chief executive Vikesh Ramsunder said the group delivered a strong and resilient performance against the background of a global humanitarian crisis and deepening economic recession locally.

'The performance of the past year, and particularly in the second half during the Covid-19 crisis, has again demonstrated that the group's core health and beauty markets and business model are resilient,' he said.

As essential healthcare service providers Clicks and UPD traded throughout the national Covid-19 lockdown, with restrictions on the sale of certain product categories in the early stages of the lockdown.

Retail health and beauty sales grew 8.4% as Clicks gained market share across most core categories. Growth was attributable to competitive pricing, differentiated products, new stores, strong online sales and the Clicks ClubCard, which grew membership to 8.6 million.

Ramsunder said trading patterns shifted as customer shopping behaviour changed in response to lockdown restrictions. 'Consumers chose to shop closer to home and shop less frequently. Many stayed home and shopped online to reduce the risk of contracting Covid-19, opting for the convenience of home delivery. This contributed to our online store showing phenomenal growth of 361% for the second half, making it our largest and fastest growing store.'

The convenience of the Clicks store network was also an advantage during the crisis. 'We have 74% of our stores located in convenience and neighbourhood shopping centres which largely negated the significant slowdown in foot traffic at super regional and regional malls across the country.'

Clicks opened 39 stores during the year to expand its retail footprint to 743 stores. The pharmacy network was increased to 585 following the opening of 40 pharmacies. '50% of the country's population now live within 6 kilometres of a Clicks pharmacy,' he said.

UPD grew turnover by 11.2% and continued to gain market share after securing new wholesale and bulk distribution contracts. Business to the private hospital and independent pharmacy channels grew strongly due to increased demand for medicines and healthcare products during the Covid-19 pandemic. UPD's total managed turnover, combining wholesale and bulk distribution, increased by 11.7% to R23.6 billion.

On the trading outlook for the new financial year, Ramsunder said the consumer environment is expected to be extremely constrained in the year ahead.

'The continuing impact of Covid-19 and the socio-economic challenges arising from the lockdown, particularly the expected widespread job losses, will make the months ahead extremely challenging.

'Our business has traded well in weak consumer markets over an extended period and has adapted to the new market dynamics arising out of the Covid-19 crisis. The group has a robust balance sheet and generates strong cash flows, and we are confident of continuing to create value for our shareholders,' he said.

Ends
Issued by Tier 1 Investor Relations on behalf of Clicks Group
For further information kindly contact
Graeme Lillie
Tier 1 Investor Relations
021 702 3102 / 082 468 1507

Disclaimer

Clicks Group Limited published this content on 22 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 October 2020 06:09:11 UTC


© Publicnow 2020
All news about CLICKS GROUP LIMITED
11/23CLS : CLICKS GROUP LIMITED - No Change Statement and Notice of Annual General Me..
PU
10/22CLICKS : S.Africa's Clicks Group aims to sell COVID-19 vaccine once country gets..
RE
10/22CLS : CLICKS GROUP LIMITED - Reviewed Annual Group Results For The Year Ended 31..
PU
10/22CLICKS : Earnings up 14% as clicks group posts resilient performance in covid-19..
PU
10/22CLICKS GROUP LIMITED : Annual results
CO
09/23CLICKS : Nkoana-Mashabane and Clicks Group in Transformation Talks
AQ
09/22CLS : CLICKS GROUP LIMITED - Appointment of Independent Non-Executive Director t..
PU
09/15CLS : CLICKS GROUP LIMITED - Resignation of Non-Executive Director
PU
09/14TRESemmé hair ad angers South Africans still hurting from racist past
RE
09/14TRESemmé hair ad angers South Africans still hurting from racist past
RE
More news
Financials
Sales 2021 37 481 M 2 429 M 2 429 M
Net income 2021 2 069 M 134 M 134 M
Net cash 2021 2 707 M 175 M 175 M
P/E ratio 2021 28,7x
Yield 2021 2,24%
Capitalization 59 187 M 3 880 M 3 836 M
EV / Sales 2021 1,51x
EV / Sales 2022 1,37x
Nbr of Employees 15 582
Free-Float 99,9%
Chart CLICKS GROUP LIMITED
Duration : Period :
Clicks Group Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CLICKS GROUP LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 258,33 ZAR
Last Close Price 238,02 ZAR
Spread / Highest target 15,1%
Spread / Average Target 8,53%
Spread / Lowest Target 4,61%
EPS Revisions
Managers
NameTitle
Vikesh Ramsunder Chief Executive Officer & Executive Director
David Morris Nurek Independent Non-Executive Chairman
Michael Fleming Chief Financial Officer & Executive Director
Martin Rosen Independent Non-Executive Director
Fatima Abrahams Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
CLICKS GROUP LIMITED-6.17%3 880
WALGREENS BOOTS ALLIANCE, INC.-33.85%33 771
MCKESSON CORPORATION30.13%28 902
CARDINAL HEALTH, INC.6.33%15 780
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.102.79%8 803
WELCIA HOLDINGS CO., LTD.21.44%8 397